Literature DB >> 30903944

Investigation of new quinoline derivatives as promising inhibitors of NTPDases: Synthesis, SAR analysis and molecular docking studies.

Komal Hayat1, Saira Afzal2, Altaf Saeed1, Amna Murtaza1, Shafiq Ur Rahman2, Khalid Mohammed Khan3, Aamer Saeed1, Sumera Zaib2, Joanna Lecka4, Jean Sévigny4, Jamshed Iqbal5, Abbas Hassan6.   

Abstract

Nucleoside triphosphate diphosphohydrolases (NTPDases), an important class of ectonucleotidases, are responsible for the sequential hydrolysis of extracellular nucleotides. However, over-expression of NTPDases has been linked with various pathological diseases e.g. cancer. Thus, to treat these diseases, the inhibitors of this class of enzyme are of interest. The significance of this class of enzyme encouraged us to synthesize a new class of quinoline derivatives with the aim to find selective and potent inhibitors of NTPDases. Therefore, a mild and efficient synthetic route was established for the synthesis of quinoline derivatives. The reaction was catalyzed by molecular iodine to afford the substituted quinoline derivatives. All the synthetic derivatives (3a-3w) were evaluated for their potential to inhibit the h-NTPDase1, 2, 3 and 8. Most of the compounds were identified as dual inhibitors of h-NTPDase1 and 8 with lower effects on h-NTPDase2 and 3. Two compounds i.e.3f and 3t were identified as selective inhibitor of h-NTPDase1 whereas the compound 3s inhibited the h-NTPDase8 selectively. Moreover, the compounds 3p (IC50 = 0.23 ± 0.01 µM), 3j (IC50 = 21.0 ± 0.03 µM) 3d (IC50 = 5.38 ± 0.21 µM) and 3c (IC50 = 1.13 ± 0.04 µM) were found to be the most potent inhibitors of h-NTPDase1, 2, 3 and 8, respectively. To determine the binding interaction, molecular docking studies were also carried out.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Iodine catalysis; NTPDase inhibitors; Quinoline synthesis; Structure-activity relationship

Year:  2019        PMID: 30903944     DOI: 10.1016/j.bioorg.2019.03.019

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  3 in total

1.  CD39 and CD73 as Promising Therapeutic Targets: What Could Be the Limitations?

Authors:  Ana Maria Oliveira Battastini; Fabricio Figueiró; Daniela Bitencourt Rosa Leal; Pedro Henrique Doleski; Maria Rosa Chitolina Schetinger
Journal:  Front Pharmacol       Date:  2021-03-11       Impact factor: 5.810

2.  Computational and biological studies of novel thiazolyl coumarin derivatives synthesized through Suzuki coupling.

Authors:  Shaista Parveen; Saima Kalsoom; Rifhat Bibi; Ambreen Asghar; Abdul Hameed; Waqar Ahmed; Abbas Hassan
Journal:  Turk J Chem       Date:  2020-12-16       Impact factor: 1.239

Review 3.  E-NTPDases: Possible Roles on Host-Parasite Interactions and Therapeutic Opportunities.

Authors:  Lisvane Paes-Vieira; André Luiz Gomes-Vieira; José Roberto Meyer-Fernandes
Journal:  Front Cell Infect Microbiol       Date:  2021-11-09       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.